# TransMedics Group (TMDX) — Analyst Forecast

TMDX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/tmdx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 8 | 4 | 0 | 12 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $77.00 | $102.83 | $120.00 | 6 |

Last price $76.52 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 13, 2026 | Canaccord Genuity | Maintained | Buy | $94.00 |
| Oct 7, 2026 | Barclays | Initiated Coverage | Overweight | $120.00 |
| Sep 8, 2026 | TD Cowen | Maintained | Buy | $120.00 |
| Aug 5, 2026 | Piper Sandler | Maintained | Overweight | $100.00 |
| Aug 5, 2026 | UBS | Maintained | Neutral | $77.00 |
| Aug 3, 2026 | Needham | Maintained | Buy | $106.00 |
| Jul 28, 2026 | UBS | Initiated Coverage | Neutral | $80.00 |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | $90.00 |
| Jul 1, 2026 | TD Cowen | Maintained | Buy | $120.00 |
| Jun 30, 2026 | Canaccord Genuity | Maintained | Buy | $124.00 |
| Jun 18, 2026 | Stifel | Maintained | Hold | $80.00 |
| May 26, 2026 | Stifel | Maintained | Hold | $75.00 |
| May 6, 2026 | Needham | Maintained | Buy | $142.00 |
| May 6, 2026 | Piper Sandler | Maintained | Overweight | $120.00 |
| May 6, 2026 | Stifel | Maintained | Hold | $85.00 |
| May 6, 2026 | TD Cowen | Maintained | Buy | $120.00 |
| May 6, 2026 | Canaccord Genuity | Maintained | Buy | $124.00 |
| Apr 6, 2026 | Evercore ISI Group | Maintained | Outperform | $118.00 |
| Mar 9, 2026 | Stifel | Maintained | Hold | $130.00 |
| Feb 25, 2026 | Needham | Maintained | Buy | $174.00 |

## Frequently Asked Questions

### What is the price target for TMDX stock?

The average 12-month analyst price target for TransMedics Group (TMDX) is $102.83, with a high estimate of $120.00 and a low of $77.00, across 6 analysts.

### Is TMDX a buy, sell, or hold?

Analysts covering TransMedics Group currently average a Buy rating: 8 buy, 4 hold and 0 sell, from 12 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for TMDX?

The average price target of $102.83 implies 34.39% upside from the last price of $76.52.

### What is the latest analyst rating on TMDX?

On Oct 13, 2026, Canaccord Genuity maintained TransMedics Group at Buy with a price target of $94.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).